1. Home
  2. DXLG vs ATNM Comparison

DXLG vs ATNM Comparison

Compare DXLG & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Destination XL Group Inc.

DXLG

Destination XL Group Inc.

N/A

Current Price

$0.64

Market Cap

33.0M

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.12

Market Cap

31.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DXLG
ATNM
Founded
1976
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.0M
31.7M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
DXLG
ATNM
Price
$0.64
$1.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$1.50
$4.50
AVG Volume (30 Days)
25.7K
166.9K
Earning Date
05-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
0.71
Revenue
$435,017,000.00
$90,000.00
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.09
N/A
P/E Ratio
N/A
$1.58
Revenue Growth
N/A
11.11
52 Week Low
$0.44
$0.74
52 Week High
$1.58
$1.81

Technical Indicators

Market Signals
Indicator
DXLG
ATNM
Relative Strength Index (RSI) 51.63 70.97
Support Level $0.62 $0.94
Resistance Level $0.74 $1.27
Average True Range (ATR) 0.04 0.07
MACD 0.01 0.04
Stochastic Oscillator 58.65 91.56

Price Performance

Historical Comparison
DXLG
ATNM

About DXLG Destination XL Group Inc.

Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store and Direct business. The company have two principal operating segments: company's stores and direct business.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: